Empagliflozin inhibits macrophage inflammation through AMPK signaling pathway and plays an anti-atherosclerosis role

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China

This publication has 27 references indexed in Scilit: